“…Furthermore, compound (75) The antitubercular activity of compounds (78d), (79b), (80b), (81c), and (81d) was superior with compound 80b showing 95 percent inhibition equivalent to that of standard drug rifampicin. (Scheme 16) [31] Nareshvarma Seelam et al reported the development of a new family of fused pyrazolo [30,40 : 4,5] thiazolo [3,2-b], [1,2,4]triazole (86a-h), Isoxazolo [30,40 : 4,5] thiazolo [3,2-b] [1,2,4,]triazole (87a-h) moieties by the reaction of 4-methyl benzoyl thiosemicarbazide with the suitable chemical reagents yielded [1,2,4]-triazole moieties using innovative conventional procedures. By using the crucial intermediate (84), condensation of Ethyl-p-methyl benzoate with thiosemicarbazide at reflux temperature led to the formation of compounds (86a-h) and (87a-h).…”